9rules - The best content from the independent web.

Browse 9rules By - Great blogs sorted by topic at 9rules.

Pharma Strategy Blog By Sally Church

Member Since 2009 of the Science Community

Recent Posts

Developing a predictive biomarker for PARP inhibition »

Posted Feb 07, 2014

Update on RAF resistance in metastatic melanoma »

Posted Jan 31, 2014

Red and Green Flags in cancer research and development »

Posted Jan 24, 2014

Will intermittent dosing transform TKI therapy in cancer research? »

Posted Jan 17, 2014

Making a difference in NHL and CLL: an interview with Dr Carol Gallagher »

Posted Jan 10, 2014

Comment on Medivation announce interim results of PREVAIL in pre-chemotherapy CRPC by maverickny »

Posted Oct 30, 2013

Comment on Medivation announce interim results of PREVAIL in pre-chemotherapy CRPC by ecitygirl »

Posted Oct 27, 2013

Medivation announce interim results of PREVAIL in pre-chemotherapy CRPC »

Posted Oct 22, 2013

Comment on The CLL Landscape is rapidly a’changing… by SBOuellette »

Posted Oct 22, 2013

Can Merck make an impact in pancreatic cancer? »

Posted Oct 22, 2013

Comment on Removing the PD-1 brake enhances the effect on adoptive CAR T cells by MJ »

Posted Oct 21, 2013

Removing the PD-1 brake enhances the effect on adoptive CAR T cells »

Posted Oct 16, 2013

The CLL Landscape is rapidly a’changing… »

Posted Oct 10, 2013

Update on KRAS and NRAS mutations in colorectal cancer »

Posted Sep 19, 2013

What’s hot at ECCO 2013 – Preview of late breakers and PI3K abstracts »

Posted Sep 17, 2013

Comment on Transformative antibody technology in cancer research by Ed Boren »

Posted Jul 30, 2013

Transformative antibody technology in cancer research »

Posted Jul 30, 2013

Update on iNHL and CLL – idelalisib, obinutuzumab and ibrutinib »

Posted Jul 26, 2013

Exciting times in CLL: an ASCO 2013 interview with Dr Susan O’Brien »

Posted Jun 10, 2013

Comment on ASCO 2013 Highlights Part 2 by maverickny »

Posted May 29, 2013